Georgetown University
4 clinical trials · 4 recruiting · OTHER
Trials by Georgetown University
RECRUITINGPhase 1 / Phase 2NCT05256745
RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer
This is a pilot study to evaluate the effects of azeliragon to decrease cardiac toxicity from chemotherapy and the safety of azelirgaon when given with chemotherapy. The...
Sponsor: Georgetown UniversityEnrolling: 483 locations
Cancer Related Cognitive DeclineNon-metastatic Breast Cancer
RECRUITINGPhase 2NCT06015724
Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and...
The goal of this clinical trial is to test the safety and tolerability of anti-CD38 monoclonal antibody (mAb), daratumumab, in combination with KRAS vaccine (Targovax...
Sponsor: Georgetown UniversityEnrolling: 542 locations
Pancreatic Ductal AdenocarcinomaRefractory Non-Small Cell Lung Cancer
RECRUITINGNCT06853925
Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life...
The goal of this clinical trial is to learn if adult patients diagnosed with differentiated thyroid cancer can easily use and benefit from an online tool aimed to provide patients...
Sponsor: Georgetown UniversityEnrolling: 881 location
Thyroid Neoplasms
RECRUITINGNCT07221747
PathToScale: The PERSIST Trial
The purpose of this study is to identify the effectiveness of a bundle of strategies to support continuation of clients on pre-exposure prophylaxis, including long-acting...
Sponsor: Georgetown UniversityEnrolling: 99001 location
Oral Pre-exposure Prophylaxis (PrEP)Long-acting Injectable Cabotegravir for PrEP